Market Overview:
The global high content screening market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for high content screening services and products due to the growing prevalence of target-based drug discovery and development programs, rising R&D expenditure by pharmaceutical and biotechnology companies, and technological advancements in HCS platforms. The global high content screening market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into consumables, microplates, instruments, software & services. The consumables segment accounted for the largest share of the global high content screening market in 2017 owing to their low cost as compared to other types of HCS products and wide applicability in various research applications.
Product Definition:
High content screening is a technique used to assay the activity of many different proteins or genes at the same time. This approach can be used to identify which proteins are important for a particular cellular process, or to study how different genes interact with each other.
Consumables:
Consumables, it's usage.
Consumables are the materials that are used more than once during the process of testing. It includes reagents, kits & assays as well as software. The factors that propel their demand include growing need for consumables in laboratories and increasing R&D activities by biotechnology & pharmaceutical companies to develop novel drugs.
Microplates:
Microplates are small wells used in high content screening (HCS) market for testing biological samples. They help in creating a standardized and controlled environment required for the detection of proteins, enzymes, & other biomolecules. It helps to standardize the assay procedure by eliminating variations due to different batches or sources of reagents used by various laboratories.
Application Insights:
The primary & secondary screening segment dominated the global market in 2017. This is attributed to the increasing prevalence of cancer and other infectious diseases across the globe. According to WHO, it is estimated that around 8.8 million people died from cancer in 2016 globally, with 1 death occurring every 6 seconds on an average. The compound profiling segment is expected to witness lucrative growth over the forecast period owing to its ability of providing rapid results for drug discovery and development programs at a reduced cost as compared with traditional high content screening methods such as western blotting and gel extraction assays.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of global players, advanced healthcare infrastructure and high adoption rate for new technologies are some factors contributing to its growth. Furthermore, increasing government funding is also expected to drive the regional market over the forecast period.
Asia Pacific is expected to grow at a lucrative rate during the forecast period owing to rising disposable income coupled with growing demand for consumer health products & services resulting into increased investments by international companies such as GE Healthcare; Siemens; Roche Diagnostics Corporation; Abbott Laboratories among others which will fuel industry expansion over next eight years The Middle East region has potential growth opportunities due towards increasing prevalence of chronic diseases such as cancer.
Growth Factors:
- Increasing demand for high content screening services due to the increasing number of drug candidates in the development pipeline
- The growing use of high content screening by pharmaceutical and biotechnology companies for target identification, lead discovery, and preclinical studies
- The increasing demand for HCS from contract research organizations (CROs) and research institutes
- The rising adoption of high content screening by small-molecule drug developers
- Growing investments in life science research
Scope Of The Report
Report Attributes
Report Details
Report Title
High Content Screening Market Research Report
By Type
Consumables, Microplates, Instruments, Software and Service
By Application
Primary & Secondary Screening, Compound Profiling, Target Identification & Validation
By Companies
Molecular Devices, Thermo Fisher Scientific, PerkinElmer Inc., Becton, GE Healthcare, Dickinson and Company, Merck KGaA, Cell Signaling Technology, Thorlabs, Inc., Genedata AG, Yokogawa Electric Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
236
Number of Tables & Figures
166
Customization Available
Yes, the report can be customized as per your need.
Global High Content Screening Market Report Segments:
The global High Content Screening market is segmented on the basis of:
Types
Consumables, Microplates, Instruments, Software and Service
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Primary & Secondary Screening, Compound Profiling, Target Identification & Validation
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Molecular Devices
- Thermo Fisher Scientific
- PerkinElmer Inc.
- Becton
- GE Healthcare
- Dickinson and Company
- Merck KGaA
- Cell Signaling Technology
- Thorlabs, Inc.
- Genedata AG
- Yokogawa Electric Corporation
Highlights of The High Content Screening Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Consumables
- Microplates
- Instruments
- Software and Service
- By Application:
- Primary & Secondary Screening
- Compound Profiling
- Target Identification & Validation
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the High Content Screening Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
High content screening is a process that uses technology to identify potential health risks and/or benefits of a product before it is sold to consumers. High content screening can include things like analyzing ingredients, looking for contaminants or toxins, and checking for adverse side effects.
Some of the key players operating in the high content screening market are Molecular Devices, Thermo Fisher Scientific, PerkinElmer Inc., Becton, GE Healthcare, Dickinson and Company, Merck KGaA, Cell Signaling Technology, Thorlabs, Inc., Genedata AG, Yokogawa Electric Corporation.
The high content screening market is expected to grow at a compound annual growth rate of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 High Content Screening Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 High Content Screening Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 High Content Screening Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the High Content Screening Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global High Content Screening Market Size & Forecast, 2018-2028
4.5.1 High Content Screening Market Size and Y-o-Y Growth
4.5.2 High Content Screening Market Absolute $ Opportunity
Chapter 5 Global High Content Screening Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 High Content Screening Market Size Forecast by Type
5.2.1 Consumables
5.2.2 Microplates
5.2.3 Instruments
5.2.4 Software and Service
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global High Content Screening Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 High Content Screening Market Size Forecast by Applications
6.2.1 Primary & Secondary Screening
6.2.2 Compound Profiling
6.2.3 Target Identification & Validation
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global High Content Screening Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 High Content Screening Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America High Content Screening Analysis and Forecast
9.1 Introduction
9.2 North America High Content Screening Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America High Content Screening Market Size Forecast by Type
9.6.1 Consumables
9.6.2 Microplates
9.6.3 Instruments
9.6.4 Software and Service
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America High Content Screening Market Size Forecast by Applications
9.10.1 Primary & Secondary Screening
9.10.2 Compound Profiling
9.10.3 Target Identification & Validation
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe High Content Screening Analysis and Forecast
10.1 Introduction
10.2 Europe High Content Screening Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe High Content Screening Market Size Forecast by Type
10.6.1 Consumables
10.6.2 Microplates
10.6.3 Instruments
10.6.4 Software and Service
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe High Content Screening Market Size Forecast by Applications
10.10.1 Primary & Secondary Screening
10.10.2 Compound Profiling
10.10.3 Target Identification & Validation
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific High Content Screening Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific High Content Screening Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific High Content Screening Market Size Forecast by Type
11.6.1 Consumables
11.6.2 Microplates
11.6.3 Instruments
11.6.4 Software and Service
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific High Content Screening Market Size Forecast by Applications
11.10.1 Primary & Secondary Screening
11.10.2 Compound Profiling
11.10.3 Target Identification & Validation
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America High Content Screening Analysis and Forecast
12.1 Introduction
12.2 Latin America High Content Screening Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America High Content Screening Market Size Forecast by Type
12.6.1 Consumables
12.6.2 Microplates
12.6.3 Instruments
12.6.4 Software and Service
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America High Content Screening Market Size Forecast by Applications
12.10.1 Primary & Secondary Screening
12.10.2 Compound Profiling
12.10.3 Target Identification & Validation
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) High Content Screening Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) High Content Screening Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) High Content Screening Market Size Forecast by Type
13.6.1 Consumables
13.6.2 Microplates
13.6.3 Instruments
13.6.4 Software and Service
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) High Content Screening Market Size Forecast by Applications
13.10.1 Primary & Secondary Screening
13.10.2 Compound Profiling
13.10.3 Target Identification & Validation
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 High Content Screening Market: Competitive Dashboard
14.2 Global High Content Screening Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Molecular Devices
14.3.2 Thermo Fisher Scientific
14.3.3 PerkinElmer Inc.
14.3.4 Becton
14.3.5 GE Healthcare
14.3.6 Dickinson and Company
14.3.7 Merck KGaA
14.3.8 Cell Signaling Technology
14.3.9 Thorlabs, Inc.
14.3.10 Genedata AG
14.3.11 Yokogawa Electric Corporation
